Response to high-dose interferon-α after failure of standard therapy in MPGN associated with hepatitis C virus infection

American Journal of Kidney Diseases

Volumn 30, Issue 1, 1997, Pages 113-115

  Sarac, Erdal ^a   Bastacky, Sheldon ^a   Johnson, John P ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cryoglobulinemia; Hepatitis C virus; Interferon; Membranoproliferative glomerulonephritis

Indexed keywords

ALPHA INTERFERON; CRYOGLOBULIN; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; CRYOGLOBULINEMIA; DOSE RESPONSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; HYPOCOMPLEMENTEMIA; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030745901     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90572-2     Document Type: Article

References (10)

1. Johnson RJ, Wilson R, Yamabe H, Couser WG, Alpers C, Wener MH, Davis C, Gritch DR: Renal manifestations of hepatitis C virus infection. Kidney Int 46:1255-1263, 1994
2. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massuzza M, Vendarmin G, Comotti B, Tanzi E, Scudeller G, Zanetti A: Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117:573-577, 1992
3. Agnello V, Chung R, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490-1495, 1992
4. Johnson RJ, Gritch D, Yamabe H, Hart J, Bacchi CE, Hartell P, Couser WG, Corey L, Wener MH, Alpers CE, Wilson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465-470, 1993
5. Yamabe H, Fukushi K, Ohsawa H, Miyata M, Inuma H, Sasaki T, Kaizuka A, Tamura N, Tsunoda S, Fujita Y, Onodera K: Hepatitis C virus infection may be an important cause of membranoproliferative glomerulonephritis. J Am Soc Nephrol 4:291, 1993 (abstr)
6. Johnson RJ, Gritch DR, Couser WG, Alpers CE, Wilson J, Chung M, Hart J, Wilson R: Hepatitis C virus-associated glomerulonephritis: Effect of alpha-interferon therapy. Kidney Int 46:1700-1704, 1994
7. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Scroni PL, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tanzi E, Zanetti A: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751-756, 1994
8. Davis GL, Balant LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, VanTheil DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A: Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 321:1501-1506, 1989
9. Di Bisceglie AM, Martin P, Kassianides C, Lister-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagel JH: Recombinant interferon alfa therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial. N Engl J Med 321:1506-1510, 1989
10. Yamabe H, Johnson RJ, Gritch DR, Osawa H, Inuma H, Sasaki T, Kaizuka M, Tamura N, Tsunoda S, Fukita Y, Sato A, Onodera K: Membranoproliferative glomerulone-phritis associated with hepatitis C virus infection responsive to interferon-α. Am J Kidney Dis 25:67-69, 1995